LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
Recruiting now NCT07143110
Run by AstraZeneca · for 18 to 130 · All sexes
What this study is about
LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.
Who can join (things the study team will check)
✅ You may be able to join if…
- Patients with lung cancer between January 1, 2018 and end of the Selection Period.
- Patient is 18 years of age or older on diagnosis date.
- Patient has at least 12 months of health insurance coverage prior to the diagnosis date.
🚫 You may not be able to join if…
- Diagnosed with any other cancer in the 5-year period prior to January 1, 2018.
- Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis.
- Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type).
- Non-Ontario or non-Alberta resident on diagnosis date.
Where this trial is running
- Research Site, Calgary, Alberta, Canada
- Research Site, Toronto, Ontario, Canada
Who to contact
AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07143110.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.